
Thomas Macpherson, Nintai Partners
Advertisement
Articles by Thomas Macpherson, Nintai Partners

Advertisement
Latest Updated Articles
The next generation of MDMPublished: October 29th 2014 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Trade & Channel Strategies 2025: The $405 Billion Patent Cliff Demands Partnership and Adaptive Market Access Strategies
2
How AI Control Towers and Digital Twins Can Restore Pharmaceutical Profit Margins
3
Novartis’ $23 Billion Manufacturing Investment Anchors Industry Shift Toward US Onshoring
4
Pharma Pulse: Amgen's Uplizna Secures CD19 Approval for Myasthenia Gravis, as Asthma Biologic Switches Highlight Efficacy Expectations Gap
5
